MP37-04 PREOPERATIVE REBOUND OF ANTI-ABO BLOOD TYPE ANTIBODY IS A RISK FACTOR OF ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS EVEN IN RITUXIMAB ERA